Global Cell-based Assays Market by Product, Application & End-user - Forecast to 2018

DUBLIN, May 16, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/n87dnx/cellbased_assays) has announced the addition of the "Cell-based Assays Market by Product, Application & End-user - Global Forecast to 2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Cell-based assays offer a sensitive and reliable technology that facilitates live cell studies for various research-based and commercial applications. These assays are emerging as a preferred tool when compared to other competing methods such as animal tests and biochemical assays. Cell based assays are more cost and time effective and have higher throughput when compared with conventional animal tests. Also, they produce accurate results and present wider range of applications than the biochemical assays. These are the major factors driving the growth of market.

The global cell-based assays market is segmented on the basis of products, applications, and end users. The products market is further subdivided into consumables (including reagents and assay kits, microplates and cell lines), instruments (detection and screening instruments such as microplate readers, flow cytometers, label-free detection instruments fluorescence microscopes, high content screening instruments and automation and high throughput screening instruments), software and cell based assay development services. Major types of cell based assays captured in the report include cell growth assays, cell death assays, second messenger assays and reporter gene assays.

Based on applications, the cell based assays market is categorized into basic research, drug discovery, ADME, predictive toxicology and other applications. Drug discovery represents the largest share of amongst these applications. With rapid developments in fields such as cell biology, genomics, proteomics and bioinformatics, the number of potential drug candidates has risen significantly, and so have the drug discovery studies.

Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs).

Based on geography, this market is further segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share of cell based assay in 2013, followed by Europe and Asia. However, the Asian market is expected to witness a healthy growth over the next five years due to the mushrooming CRO market in this region.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Premium Insights

4 Market Overview

5 Cell-Based Assays Market, By Product

6 Cell-Based Assays Market, By Application

7 Cell-Based Assays Market, By End User

8 Cell-Based Assays, By Geography

9 Competitive Landscape

10 Company Profiles

Companies Mentioned:

• Becton, Dickinson and Company
• Cell Signaling Technology
• Cisbio Bioassays (Argos Soditic)
• Danaher Corporation
• Discoverx
• EMD Millipore (A Subsidiary of Merck Kgaa)
• Ge Healthcare (Subsidiary of General Electric Company)
• Life Technologies (Thermo Fisher Scientific)
• Perkinelmer, Inc.
• Promega Corporation

For more information visit http://www.researchandmarkets.com/research/n87dnx/cellbased_assays

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net